chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Pain, Pyrexia, Rhinorrhoea, Urine analysis
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of an unknown age and gender. The patient's medical history, historical drugs and concomitant therapies were not reported. The patient's concurrent conditions included acquired immunodeficiency syndrome. On 05-JAN-2018, the patient was vaccinated with one dose of VARIVAX subcutaneously (dose, lot number and expiration date were not reported) for prophylaxis (contraindicated product administered). Other suspect therapies included sterile diluent (MERCK). On an unknown date in January 2018, the patient had a CD4 cell count which was in 48 (units not reported) (CD4 lymphocytes abnormal). The outcome of CD4 lymphocytes abnormal was unknown. The causal relationship between CD4 lymphocytes abnormal and VARIVAX was not reported.
Sex: U
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Acquired immunodeficiency syndrome, CD4 lymphocytes decreased, Immunology test, Immunology test abnormal, Rash generalised
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of an unknown age and gender. The patient's medical history, historical drugs and concomitant therapies were not reported. The patient's concurrent conditions included acquired immunodeficiency syndrome. On 05-JAN-2018, the patient was vaccinated with one dose of VARIVAX subcutaneously (dose, lot number and expiration date were not reported) for prophylaxis (contraindicated product administered). Other suspect therapies included sterile diluent (MERCK). On an unknown date in January 2018, the patient had a CD4 cell count which was in 48 (units not reported) (CD4 lymphocytes abnormal). The outcome of CD4 lymphocytes abnormal was unknown. The causal relationship between CD4 lymphocytes abnormal and VARIVAX was not reported.
Age: 16.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Cellulitis, Culture negative, Incisional drainage, Injected limb mobility decreased, Injection site erythema
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 16-year-old female patient. The patient's current condition included primary immune deficiency. Her pertinent medical history included repeated infections. She had no known drug reactions or allergies. On 27-DEC-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 (exact dose, dose number, route of administration were not reported; lot # N012127 with the expiration date of 20-JAN-2019) in the left deltoid, for primary immune deficiency. Concomitant therapies included midodrine hydrochloride (MIDRON, reported as "MIDRONE") and fluoxetine. On 08-JAN-2018, the patient had a a fever of 99.8 Fahrenheit degrees. The injection site became painful, red, swollen and hot to touch. On 08-JAN-2018, the patient was diagnosed with cellulitis by an unspecified healthcare provider and on the same day, admitted to a hospital. On 08-JAN-2018, the patient had a surgical drainage of the left arm, which yielded pus but had negative cultures. The patient was prescribed an unspecified 10-day course of clindamycin by an unspecified healthcare provider on an unspecified date in January 2018. On 11-JAN-2018, the patient's fever, pain and swelling improved, but did not resolve (present status was reported as recovering). It was not reported if the patient was discharged from the hospital. The causality assessment between cellulitis and PNEUMOVAX 23 was not provided. The reporter considered the event of cellulitis to be a significant disability or incapacity, as the patient was not able to move her arm. Upon internal review, the event of cellulitis was considered to be medically significant.
Age: 16.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Purulent discharge, Pyrexia
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 16-year-old female patient. The patient's current condition included primary immune deficiency. Her pertinent medical history included repeated infections. She had no known drug reactions or allergies. On 27-DEC-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 (exact dose, dose number, route of administration were not reported; lot # N012127 with the expiration date of 20-JAN-2019) in the left deltoid, for primary immune deficiency. Concomitant therapies included midodrine hydrochloride (MIDRON, reported as "MIDRONE") and fluoxetine. On 08-JAN-2018, the patient had a a fever of 99.8 Fahrenheit degrees. The injection site became painful, red, swollen and hot to touch. On 08-JAN-2018, the patient was diagnosed with cellulitis by an unspecified healthcare provider and on the same day, admitted to a hospital. On 08-JAN-2018, the patient had a surgical drainage of the left arm, which yielded pus but had negative cultures. The patient was prescribed an unspecified 10-day course of clindamycin by an unspecified healthcare provider on an unspecified date in January 2018. On 11-JAN-2018, the patient's fever, pain and swelling improved, but did not resolve (present status was reported as recovering). It was not reported if the patient was discharged from the hospital. The causality assessment between cellulitis and PNEUMOVAX 23 was not provided. The reporter considered the event of cellulitis to be a significant disability or incapacity, as the patient was not able to move her arm. Upon internal review, the event of cellulitis was considered to be medically significant.
Sex: U
Vaccine: HEP
Symptoms: No adverse event, Underdose
Clinical narrative: This spontaneous report was received from a pharmacist regarding an adult patient of unknown demographics. The patient's pertinent medical conditions and concomitant medications were not reported. On an unknown date in 2015, the patient was vaccinated with a pediatric dose of RECOMBIVAX HB (dosing details and lot # were not reported) for prophylaxis (drug administered to patient of inappropriate age). No adverse events were not reported. No product quality complaint.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report was received from a pharmacist, concerning a patient of unknown age a gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 16-JAN-2018, the patient was inadvertently vaccinated with VARIVAX lot number N022977 and expiration date of 23-AUG-2018  (dose, frequency and route were not provided) for prophylaxis, instead of ZOSTAVAX. No adverse effects. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1801USA006250:
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Immunisation, Incorrect route of drug administration, No adverse event
Clinical narrative: The first dose of vaccine was given IM, instead SQ. CMA revaccinated patient same day administering SQ (per RN instructions). As far as we know there were no adverse reaction.
Age: 69.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site rash, Pain in extremity, Peripheral swelling
Clinical narrative: Patient called our pharmacy on 2/1/18 and reported that her arm was painful, swollen and had a rash at the injection site. Patient also reported she does get a rash when given a flu shot every year. Treatment recommended was to ice her arm and take TYLENOL or ADVIL if necessary for the discomfort; also recommended calling her doctor to let know about reaction. Called her back today, 2/2/18 to check in with her and was told her arm did feel a little better (she only iced it once) and said Dr. did confirm may be reaction to vaccine but within normal side effects listed. Dr. confirmed what I had told her on Tuesday when she first called, yes a reaction but not unusual for PREVNAR, most concerned about the rash and swelling.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at injection site. No trouble breathing or itching.
Age: 73.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Injection site reaction, Rash erythematous
Clinical narrative: PATIENT PRESENTED ON 2/2/18 WITH A RED RASH THAT ENCIRCLED HER ARM ABOVE HER ELBOW. THIS WAS SEVERAL INCHES AWAY FROM THE TWO INJECTION SITES IN HER LEFT DELTOID. I ADVISED HER TO BE SEEN BY HER PCP BECAUSE I WAS NOT SURE THAT THE RASH WAS RELATED TO THE VACCINES. THE PATIENT WAS NOT EXPERIENCING ANY PAIN OR DISCOMFORT.
Age: 29.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Intense erythema, induration, tenderness and warmth on the lateral arm at the level of the bicep immediately below the injection site extending 4 inches above antecubital fossa.
Age: 1.25
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Body temperature increased, Choking, Cyanosis, Febrile convulsion, Postictal state
Clinical narrative: Pt with febrile seizure on 2-01-18 after receiving 15 month vaccines. Mom noted jaw moving side to side (2-3 min) and looked blue around her mouth, sounded like she was choking on her spit. Was sitting up, seemed like she was reactive to mom, looking at her and moving her arms. Ambulance came and she was not fighting and out of it - post ictal period. No fever noted in office (had vaccines) but temp in ambulance found to be 101. Went to ER (arrived to ER at 13:50PM) and was back to herself and no tests done since she had previous febrile seizure x 1. Has been acting like nl self since. Temp today 99 Temporal scan.
Age: 1.25
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Trismus
Clinical narrative: Pt with febrile seizure on 2-01-18 after receiving 15 month vaccines. Mom noted jaw moving side to side (2-3 min) and looked blue around her mouth, sounded like she was choking on her spit. Was sitting up, seemed like she was reactive to mom, looking at her and moving her arms. Ambulance came and she was not fighting and out of it - post ictal period. No fever noted in office (had vaccines) but temp in ambulance found to be 101. Went to ER (arrived to ER at 13:50PM) and was back to herself and no tests done since she had previous febrile seizure x 1. Has been acting like nl self since. Temp today 99 Temporal scan.
Age: 2.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: A 0.5ml dose of FLUZONE QUAD was administered in error instead of the 0.25ml dose. MD was notified, he advised cool compress and APAP in case of swelling, which was not needed, no symptoms of event detected by staff or through follow-up with patient's father the next day.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 29-DEC-2017, the patient was vaccinated with an improperly stored dose of PROQUAD (strength, dose, route of adminstration were unknown) with lot # N008825 and expiration date of 12-SEP-2018 for prophylaxis which was stored in a temperature from 6 Fahrenheit degrees (°F) to 14 °F for 24 hours. There was no previous temperature excursions. Morevoer, it was reported that the temperature excursion was not detected by a data logger. No adverse effects were reported.
Sex: U
Vaccine: MMR
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender.  Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On 25-JAN-2018, the patient was vaccinated with an improperly stored dose of M-M-R II lot # N027780, expiration date 08-AUG-2019, by subcutaneous route, for prophylaxis (strength and anatomical location were not provided). The vaccine was exposed to a temperature range of 17°C, during a time frame of 6 hours. No adverse effects were reported.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about  06-MAY-2011, the patient was vaccinated at a clinic with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent herpes zoster virus. On or about 30-AUG-2016, the patient was treated by a physician for painful vesicular outbreaks that had been present for a week. The patient was then diagnosed with herpes zoster, or shingles. The patient has been prescribed tramadol and gabapentin for management of his persistent painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about  27-MAR-2008, the patient was vaccinated at a physician office with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 29-JAN-2012, the patient was treated by a physician for painful and blistering vesicular outbreak, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Breast cancer female, Breast cancer metastatic, Decreased immune responsiveness, Herpes zoster, Infection
Clinical narrative: Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 17-JAN-2008, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 04-AUG-2016, the patient was treated by a physician's assistant for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was due for surgical intervention to treat her breast cancer [onset unknown; unclear if before or after receiving ZOSTAVAX], but due to her persistent zoster outbreaks and infections on her chest, her surgery was postponed, causing her cancer to spread (onsets unknown). The patient was prescribed VALTREX and hydrocodone/acetaminophen for management of her persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, breast cancer and surgery was postponed causing her cancer to spread were determined to be medically significant. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Rash vesicular
Clinical narrative: Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 17-JAN-2008, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 04-AUG-2016, the patient was treated by a physician's assistant for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was due for surgical intervention to treat her breast cancer [onset unknown; unclear if before or after receiving ZOSTAVAX], but due to her persistent zoster outbreaks and infections on her chest, her surgery was postponed, causing her cancer to spread (onsets unknown). The patient was prescribed VALTREX and hydrocodone/acetaminophen for management of her persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, breast cancer and surgery was postponed causing her cancer to spread were determined to be medically significant. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Decreased immune responsiveness, Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 22-MAR-2010, as prescribed by a physician and administered at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 03-APR-2014, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was prescribed valacyclovir for management of the persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report has been received from a licensed practical nurse referring to an 18 year old female patient. Information regarding the patients medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On 01-FEB-2018, the patient was vaccinated with M-M-R II lot # N020926, subcutaneous for prophylaxis. The M-M-R II was exposed to a temperature range between 47°F to 77°F, during a time frame of 216 hours. No previous temperature excursions were reported. No adverse events reported.
Age: 1.0
Sex: F
Vaccine: HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site reaction, Pyrexia, Rash papular
Clinical narrative: 12 mo F w fever Tmax 101 F wo episodes, skin rash papular-erythematous on the left upper thigh round 2x2 cm in the same location she got immunizations, started 12 days after vaccines were given on 1/19/18. TYLENOL was given PRN for fever, w f/u appt on 2/6/18.
Age: 49.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Nodule, Pyrexia, Swelling
Clinical narrative: Swelling, fever, redness, knot.
Age: 55.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Redness, swelling, warm to touch and painful.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC13, VARCEL
Symptoms: Injection site discharge, Injection site erythema, Injection site infection, Injection site swelling, Injection site warmth
Clinical narrative: Mom called to report that child had developed Chicken Pox and injection site infection. She stated that child developed fever up to 102.3 at 3-4 days after vaccines given and site was swollen, raised, purple-red and hot to touch. He was taken to an urgent care clinic and dx with infection and chicken pox. He was started on an antibiotic for the infection. Mother claims that site of infection was "oozing clear fluid". Also states that lesions were tested "and it is chicken pox".
Age: 1.0
Sex: M
Vaccine: HEPA, PNC13, VARCEL
Symptoms: Pyrexia, Skin lesion, Varicella post vaccine, Varicella virus test positive
Clinical narrative: Mom called to report that child had developed Chicken Pox and injection site infection. She stated that child developed fever up to 102.3 at 3-4 days after vaccines given and site was swollen, raised, purple-red and hot to touch. He was taken to an urgent care clinic and dx with infection and chicken pox. He was started on an antibiotic for the infection. Mother claims that site of infection was "oozing clear fluid". Also states that lesions were tested "and it is chicken pox".
Age: 36.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Throwing up a lot. Severe diarrhea.That lasted for hours.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV, PNC13
Symptoms: Crying, Gait disturbance, Injection site erythema, Injection site swelling
Clinical narrative: Mother brought child patient back in 2 days after immunizations were given. Mom stated right thigh was red, swollen. Mother stated child patient was in pain, crying, didn't want to walk. Mother stated no medication was given to child patient for symptomatic treatment.
Age: 63.0
Sex: M
Vaccine: FLU4
Symptoms: Hypersensitivity, Rash
Clinical narrative: Patient received vaccine on 1/23/18 and started having adverse effects on 1/24/18. Patient presented to pharmacy on 1/26/18 after seeing provider with an antibiotic prescription for KEFLEX thinking it was cellulitis. Later on 1/30/18 patient presented again stating it was not cellulitis, but was diagnosed as a delayed onset allergy reaction. She received treatment and was seeing improvement in symptoms. She experienced a rash on both arms and part of her trunk.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Insomnia, Pain in extremity, Peripheral swelling
Clinical narrative: Patient's arm is still sore, red, and swollen among his entire upper right extremity. His most concerned side effect is insomnia.
Age: 54.0
Sex: M
Vaccine: HEPAB
Symptoms: Body temperature increased, Ear swelling, Erythema, Malaise, Swelling face
Clinical narrative: 1/29/18-Client felt ill in the evening and worsened. 1/31-Client woke up with swelling and redness of right ear and right side of face near corner of right eye and right forehead. 2/1-redness progressed to left side of face and forehead. 2/2/18-Client saw PCP who diagnosed possible ear infection. Put client on clindamycin and methylprednisolone. Temp of 102.9.
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Myalgia, Nervous system disorder
Clinical narrative: PATIENT CLAIMS TO HAVE MUSCLE PAIN IN HER RIGHT ARM. SHE RECEIVED VACCINE IN OCTOBER 9, 2017, BUT DID NOT REPORT HER ISSUE UNTIL THE THIRD WEEK OF JANUARY. SHE RECEIVED A STEROID SHOT WHICH DID NOT SEEM TO HELP DURING HER DOCTORS VISIT ON 01/26/18. SHE FOLLOW UP ON 01/30/18 WITH THE PHARMACY. SHE CLAIMS THE DOCTOR THOUGHT IT WAS A NERVE ISSUE RELATED TO THE VACCINATION.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Patient came in after 1 month getting the vaccination and explains that she has been having occasional radiating pain on her arm. She also goes on to say that the pain might be due to Arthritis or related to work due to tension/stress from lifting. I advise her to see her doctor and let me know the outcome.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Eye discharge, Oropharyngeal pain, Pain, Pharyngeal erythema
Clinical narrative: Within 90 minutes of injection, throat began to swell became red and hurt. Eyes ran, fever, chills, body aches, lasted throughout the night. Swelling of throat and soreness began to subside approximately 12 hours later. Did not feel fully recovered until 2 days later.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Pharyngeal oedema, Pyrexia
Clinical narrative: Within 90 minutes of injection, throat began to swell became red and hurt. Eyes ran, fever, chills, body aches, lasted throughout the night. Swelling of throat and soreness began to subside approximately 12 hours later. Did not feel fully recovered until 2 days later.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Apnoea, Electrocardiogram normal, Eye movement disorder, Hypotonia, Seizure like phenomena
Clinical narrative: Seizure-like activity while nursing 2 days after vaccinations: shaking for a few seconds followed by a sudden loss of tone with cessation of breathing and eyes rolling to the back of the head. Patient then presented to Emergency department with mother for treatment. ECG was performed with no remarkable findings. Patient was discharged with instructions to return if symptoms recur.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Tremor
Clinical narrative: Seizure-like activity while nursing 2 days after vaccinations: shaking for a few seconds followed by a sudden loss of tone with cessation of breathing and eyes rolling to the back of the head. Patient then presented to Emergency department with mother for treatment. ECG was performed with no remarkable findings. Patient was discharged with instructions to return if symptoms recur.
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Insomnia, Mobility decreased, Musculoskeletal pain
Clinical narrative: Horrible pain in shoulder, ":robbed of a night's sleep" , and cannot raise her arm all of the way. She also states she worked for a physical therapist and knows about rotator cuff injuries. Has had a rotator cuff injury as a child.
Age: 64.0
Sex: F
Vaccine: FLUC4
Symptoms: Lip swelling
Clinical narrative: Swollen lips.
Age: 5.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Peripheral swelling, Urticaria
Clinical narrative: Patient broke out in severe Hives. Also, she has swollen fingers and pain in her wrists.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Deafness unilateral, Diarrhoea, Head discomfort, Hot flush
Clinical narrative: Patient received a vaccination on 01/29/2018, on 02/01/2018 patient called the pharmacy complaining of hearing loss in the right ear, pressure on the left side of his head, hot flashes, chills, vomiting, and diarrhea. Patient stated the symptoms started the day after he received the flu shot on 01/30/2018.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Patient received a vaccination on 01/29/2018, on 02/01/2018 patient called the pharmacy complaining of hearing loss in the right ear, pressure on the left side of his head, hot flashes, chills, vomiting, and diarrhea. Patient stated the symptoms started the day after he received the flu shot on 01/30/2018.
Age: 6.0
Sex: M
Vaccine: FLU4
Symptoms: C-reactive protein, Erythema, Skin swelling, Skin tightness, White blood cell count normal
Clinical narrative: Redness of skin from the pectoral region of the chest on the left, left arm and area around elbow; skin is swollen and tight especially around the elbow.
Age: 16.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Sore, swollen, site of injection.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Area of injection is swollen, raised and bright red. Pt's Lt. deltoid is also hot to the touch. Pt. has a fever of 100.7 taken tympanically and reports that Wednesday night it was 102.0 F. Pt. Dx'd. with cellulitis of Lt. upper extremity and is being treated with KEFLEX 500 mg.
Age: 68.0
Sex: M
Vaccine: PNC13
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: 68 y/o received pneumococcal 13 valent conjugate vaccine on 06/30/17. Presented to PCP as a walk in with right arm pain and swelling which started Saturday morning after getting a PREVNAR 13 shot on Friday afternoon. Symptoms noted to be resolving quickly without any treatment. And erythema.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, FLU4, PNC13
Symptoms: Inappropriate schedule of drug administration, Wrong drug administered
Clinical narrative: Patient was given the wrong vaccines at the wrong time. Pt received PEDIARIX, PREVNAR and FLUZONE on 2/1/18. Pt had already received PEDIARIX and PREVNAR on 1/18/18. Pt did not display any adverse reaction on 2/1/18 or 2/2/18.
Age: 1.0
Sex: M
Vaccine: HEP, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Lymphadenopathy
Clinical narrative: On 2-1-18 patient's grandmother noticed a quarter sized red bump on patient's right lateral thigh. On 2-2-18, it had grown in size so he was brought in for an appointment. He was noted to have enlarged nodes in his groin. He was treated with AUGMENTIN for presumed infection (cellulitis of right lower extremity).
Sex: U
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of fever in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional called to asked about reimbursement. On an unknown date, the patient's body temperature was recorded as 102 degree F. The healthcare professional refused to answer any further questions and asked for codes, when notified a transfer would need to occur to answer that question and asked if there were any other questions before that transfer asked for side effect information, VIS lack. Attempt was made to collect adverse events but The healthcare professional stated not having time and hung up. This case was 1 of the 2 cases, reported by the same reporter.
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Mom called in on Feb 2 to report redness and swelling at injection site. Redness keeps growing. Slight fever. Redness started the same day as injection.
Age: 16.0
Sex: F
Vaccine: FLU4, HPV4, MENB, MNQ
Symptoms: Syncope
Clinical narrative: Patient fainted after blood draw at the lab in clinic. Per lab techs patients started to "go out" after completion of blood draw and was helped down to the floor by lab techs. Per lab techs patients eyes fluttered for a few secs and then patient came around. No tonic clonic seizure or convulsions. No history of seizures. Patient had received HPV immu. approx 30-40 min ago. Patient advised to rest and go to ER if any problems.
Age: 45.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Arthralgia, Dry skin, Skin discolouration
Clinical narrative: I'm not sure of the exact type of flu vaccine used, I just chose the first one on the list above. I developed a small discoloration/rough spot within 2 inches of the injection site. It looks like a birth mark (more visible after a hot shower). Also, I have sensitivity in my right hip and upper thigh near the surface of the skin, hard to describe, no visible change, just a pain when I touch that area, feels almost like a cut. It hasn't worsened, I noticed this after the patch on my arm. It's still present at 2/3/2018. I have an old injury in my right inner hip from a bike accident that had been bothering me prior to the shot, but did not feel anything like this.
Age: 45.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Arthralgia, Dry skin, Injection site discolouration, Injection site reaction, Pain in extremity
Clinical narrative: I'm not sure of the exact type of flu vaccine used, I just chose the first one on the list above. I developed a small discoloration/rough spot within 2 inches of the injection site. It looks like a birth mark (more visible after a hot shower). Also, I have sensitivity in my right hip and upper thigh near the surface of the skin, hard to describe, no visible change, just a pain when I touch that area, feels almost like a cut. It hasn't worsened, I noticed this after the patch on my arm. It's still present at 2/3/2018. I have an old injury in my right inner hip from a bike accident that had been bothering me prior to the shot, but did not feel anything like this.
Age: 45.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Pain of skin
Clinical narrative: I'm not sure of the exact type of flu vaccine used, I just chose the first one on the list above. I developed a small discoloration/rough spot within 2 inches of the injection site. It looks like a birth mark (more visible after a hot shower). Also, I have sensitivity in my right hip and upper thigh near the surface of the skin, hard to describe, no visible change, just a pain when I touch that area, feels almost like a cut. It hasn't worsened, I noticed this after the patch on my arm. It's still present at 2/3/2018. I have an old injury in my right inner hip from a bike accident that had been bothering me prior to the shot, but did not feel anything like this.
Age: 15.0
Sex: M
Vaccine: FLU4
Symptoms: Abdominal pain upper, Headache, Muscle spasms, Myalgia
Clinical narrative: Visible calf muscle cramping, muscle aches, stomache pain, headache onset within 3-4 hours of administration of quad flu vaccine to previously healthy 15 year old male. Treated with gatorade, ibuprofen and rest. Symptoms worsened over 24 hours and have begun to improve, but are not fully resolved 3 days out.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Chest pain, Dyspnoea, Feeling abnormal, Pain
Clinical narrative: Employee states she felt bad two hours after receiving the vaccine. She has had trouble breathing and her body hurts but mainly her chest.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling
Clinical narrative: Local swelling around injection site.
Age: 41.0
Sex: F
Vaccine: ANTH, TYP
Symptoms: Headache, Injection site nodule, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Patient presented with fever, Headache, swollen upper right arm, painful to the touch. After the events patient still have a "knot" in the site area. No other events. No muscular problems. Patient was not seen by a provider the day of the vaccine. Patient was seen by provider on 01/03/2018.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Body temperature increased, Crying, Febrile convulsion, Gaze palsy, Influenza virus test negative
Clinical narrative: Patient experienced an rapid increase in body temperature with a rectal temperature of 103.6F registered at approximately 5:45pm on 2/1/2018. At approximately 5:50pm, patient experienced a Febrile Seizure which had convulsions of less than 2 minutes followed by approximately 2 minutes of non responsiveness. Patient did not stop breathing, but was unresponsive to vocal commands and did not focus attention from his blank gaze. Within 5 minutes, patient was fully responsive and began chattering and crying. At approximately 6:45 when we arrived at the urgent care facility and his temperature was taken temporally, he registered 99.9F with no introduction of fever reducing medications being given.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Unresponsive to stimuli
Clinical narrative: Patient experienced an rapid increase in body temperature with a rectal temperature of 103.6F registered at approximately 5:45pm on 2/1/2018. At approximately 5:50pm, patient experienced a Febrile Seizure which had convulsions of less than 2 minutes followed by approximately 2 minutes of non responsiveness. Patient did not stop breathing, but was unresponsive to vocal commands and did not focus attention from his blank gaze. Within 5 minutes, patient was fully responsive and began chattering and crying. At approximately 6:45 when we arrived at the urgent care facility and his temperature was taken temporally, he registered 99.9F with no introduction of fever reducing medications being given.
Age: 36.0
Sex: F
Vaccine: MMR
Symptoms: Mental disorder
Clinical narrative: I was administered a booster vaccine upon being granted a job at the Clinic in August of 2013. I was in a psychiatric facility for 10-days March 27, 2017 through April 3, 2017 for "psychiatric observation" at the Center and Hospital. During the observation I was subjected to numerous modalities involving ultrasonic technologies and radiofrequency modulations. I have studied these technologies and have a basic understanding of how they work. I believe that the "tests" to which I was subjected during the observation were used to set a series of radiofrequency modulations in order to use me in the commission of acts of wire fraud. These acts are connected to numerous crimes. I have also verified that my patient information has been used for financial and other transactions involving biotransference without my informed consent. I also understand this has happened to others and believe there was a large-scale human test subject experimentation process that accompanied the release of nanotech into the water stream following Hurricane Harvey. Surely you understand that not only is such possible, but also being tested in various capacities already. I however never consented to this, understand it as being used against me as retaliation and in connection to serious crimes, including racketeering and facilitating of insider trading, and also in violation of the Nuremburg Code. Please provide me with information on how I can obtain information on the batch number and confirmation as to what sort of nanotech may have been employed as part of that vaccination effort or any subsequent use of my bio-data. I ABSOLUTELY do not consent to any remote testing or use of my bio data or any engagement in radiofrequency modulations involving external sources without my express written consent and foreknowledge of the tech and stages of its development.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Erythema, Induration, Pruritus, Skin warm, Swelling
Clinical narrative: Adverse reaction- Approximately 4-5inch diameter; Swollen/hard, red, hot to touch, itchy (NO PAIN reported). Treatment- Children's MOTRIN, Children's BENADRYL at recommendation of nurse practitioner, Cold pack (tolerated briefly). Outcomes- began to go down on day 3 and continued to improve.
Age: 47.0
Sex: F
Vaccine: PPV
Symptoms: Injection site inflammation, Injection site swelling
Clinical narrative: The patient reports that she is having swelling at the injection site (inflammation).
Age: 67.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Contusion, Erythema, Immediate post-injection reaction, Injection site pain, Livedo reticularis
Clinical narrative: January 25th: very painful shot, arm sore immediately afterwards took Ibuprofen. 26th: sore arm all day. 27th: sore arm all day, dusky red, 3 inches by 4 inches (Grade 3 local reaction), took Ibuprofen. 28th: sore arm, applying alternating hot and cold compress. 29th: mottled local reaction with some bruising, arm still sore and itchy. 30th  Feb 2nd: arm slightly sore and itchy.
Age: 67.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Local reaction, Pain in extremity, Pruritus
Clinical narrative: January 25th: very painful shot, arm sore immediately afterwards took Ibuprofen. 26th: sore arm all day. 27th: sore arm all day, dusky red, 3 inches by 4 inches (Grade 3 local reaction), took Ibuprofen. 28th: sore arm, applying alternating hot and cold compress. 29th: mottled local reaction with some bruising, arm still sore and itchy. 30th  Feb 2nd: arm slightly sore and itchy.
Age: 67.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Incorrect route of drug administration, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: January 25th: very painful shot, arm sore immediately afterwards took Ibuprofen. 26th: sore arm all day. 27th: sore arm all day, dusky red, 3 inches by 4 inches (Grade 3 local reaction), took Ibuprofen. 28th: sore arm, applying alternating hot and cold compress. 29th: mottled local reaction with some bruising, arm still sore and itchy. 30th  Feb 2nd: arm slightly sore and itchy.
Age: 67.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Immediate post-injection reaction, Incorrect route of drug administration, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: January 25th: very painful shot, arm sore immediately afterwards took Ibuprofen. 26th: sore arm all day. 27th: sore arm all day, dusky red, 3 inches by 4 inches (Grade 3 local reaction), took Ibuprofen. 28th: sore arm, applying alternating hot and cold compress. 29th: mottled local reaction with some bruising, arm still sore and itchy. 30th  Feb 2nd: arm slightly sore and itchy.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Flushing, Headache, Immediate post-injection reaction, Injection site pain
Clinical narrative: Jan 25: very painful shot, arm sore immediately. 26: sore arm all day. 27: sore arm, livid reaction, 3 inches by 2 inches (Grade 3 local reaction), flushed skin on face, malaise, headache and shivering, went to bed early with Ibuprofen. 28: headache, malaise, sore and itchy arm, hot compresses. 29-31: local reaction much less livid, sore and itchy arm but not as sore, mostly better by day's end. Feb 1: itchy and discolored arm.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Lividity, Local reaction, Malaise, Pain in extremity, Pruritus
Clinical narrative: Jan 25: very painful shot, arm sore immediately. 26: sore arm all day. 27: sore arm, livid reaction, 3 inches by 2 inches (Grade 3 local reaction), flushed skin on face, malaise, headache and shivering, went to bed early with Ibuprofen. 28: headache, malaise, sore and itchy arm, hot compresses. 29-31: local reaction much less livid, sore and itchy arm but not as sore, mostly better by day's end. Feb 1: itchy and discolored arm.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Skin discolouration
Clinical narrative: Jan 25: very painful shot, arm sore immediately. 26: sore arm all day. 27: sore arm, livid reaction, 3 inches by 2 inches (Grade 3 local reaction), flushed skin on face, malaise, headache and shivering, went to bed early with Ibuprofen. 28: headache, malaise, sore and itchy arm, hot compresses. 29-31: local reaction much less livid, sore and itchy arm but not as sore, mostly better by day's end. Feb 1: itchy and discolored arm.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Headache, Immediate post-injection reaction, Incorrect route of drug administration, Injection site erythema
Clinical narrative: Jan 25: very painful shot, arm sore immediately. 26: sore arm all day. 27: sore arm, livid reaction, 3 inches by 2 inches (Grade 3 local reaction), flushed skin on face, malaise, headache and shivering, went to bed early with Ibuprofen. 28: headache, malaise, sore and itchy arm, hot compresses. 29-31: local reaction much less livid, sore and itchy arm but not as sore, mostly better by day's end. Feb 1: itchy and discolored arm.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site pain, Malaise
Clinical narrative: Jan 25: very painful shot, arm sore immediately. 26: sore arm all day. 27: sore arm, livid reaction, 3 inches by 2 inches (Grade 3 local reaction), flushed skin on face, malaise, headache and shivering, went to bed early with Ibuprofen. 28: headache, malaise, sore and itchy arm, hot compresses. 29-31: local reaction much less livid, sore and itchy arm but not as sore, mostly better by day's end. Feb 1: itchy and discolored arm.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Influenza like illness, Pain, Pain in extremity, Respiratory tract congestion, Sneezing
Clinical narrative: Pt discussed arm pain and flu-like symptoms (body aches, congestion, sneezing) but no fever. Pt taking TYLENOL and ibuprofen to alleviate.
Age: 93.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site pain, Skin warm
Clinical narrative: A roughly 5 to 6 inch area of redness, non-raised, non-broken, was presented by the patient on 2/3/18 around 3:00pm. She noted that this reaction started the evening of 2/1/18 when the vaccine was given. She described it as "hot to the touch", but not worsening or changing significantly in the last 36 hours or so since first noticing it. She also claims no systemic fever, although she has no thermometer at home to measure this. She also describes no other symptoms, other than injection-site pain.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Skin warm
Clinical narrative: Very large red area and warm on arm.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, FLU4, PNC13, RV1
Symptoms: Speech disorder
Clinical narrative: My baby stopped talking completely!!! She was babbling and making lots of different sounds before, nonstop! She was watching and repeating sounds, sounded like she was saying "hi!" when we said "hi" to her at four or five months. After vaccination she just sat quietly all day. As days passed, she made throat scraping noise to call for our attention.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site discolouration, Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: THE FIRST COUPLE DAYS AFTER THE VACCINE WAS GIVEN  THE PATIENT REPORTED REDNESS AT THE INJECTION SITE. AT DAY 5 AFTER THE VACCINE IT HAS BECOME MORE PURPLE/DARKER COLOR AT THE INJECTION SITE. IT IS ALSO WARM, TENDER TO TOUCH, AND ITCHY.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site nodule, Joint range of motion decreased, Pain in extremity, Skin warm
Clinical narrative: Sore arm, ltd. ROM and nodule at injection point initially; next day swollen red warm patch appeared not at injection point but about 2" below. Dimensions: at 24 hrs., golf ball size; 48 hrs, tennis ball size; 96 hrs 3" wide x 6"long, spreading downward and back towards elbow. Warm & tender to touch. Each day, the new expansion area is swollen but the prior days' swelling has receded. But entire area is red, warm and sore to touch. No fever, headache, other myalgias, or GI symptoms. My primary care doc not sure whether it's a reaction or cellulitis. Now 96 hrs and the reaction keeps progressing.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling, Tenderness
Clinical narrative: Sore arm, ltd. ROM and nodule at injection point initially; next day swollen red warm patch appeared not at injection point but about 2" below. Dimensions: at 24 hrs., golf ball size; 48 hrs, tennis ball size; 96 hrs 3" wide x 6"long, spreading downward and back towards elbow. Warm & tender to touch. Each day, the new expansion area is swollen but the prior days' swelling has receded. But entire area is red, warm and sore to touch. No fever, headache, other myalgias, or GI symptoms. My primary care doc not sure whether it's a reaction or cellulitis. Now 96 hrs and the reaction keeps progressing.
Age: 56.0
Sex: F
Vaccine: PNC13
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever, chills, body aches and pains, Headache.